Acorda Therapeutics Inc (NASDAQ:ACOR)

32.08
Delayed Data
As of Jul 02
 -0.01 / -0.03%
Today’s Change
28.26
Today|||52-Week Range
45.45
-21.51%
Year-to-Date

Today’s Trading

Previous close32.09
Today’s open32.00
Day’s range31.60 - 32.20
Volume359,339
Average volume (3 months)622,277
Market cap$1.4B
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)-207.41%
Earnings growth (next 5 years)+37.00%
Revenue growth (last year)+19.34%
P/E ratio98.2
Price/Sales4.33
Price/Book2.58

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc+0.06+0.73%
MACKMerrimack Pharmaceut...-0.12-0.99%
RGENRepligen Corp-1.17-2.84%
INSMInsmed Inc+0.15+0.63%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$401.5M
Annual profit (last year)$17.7M
Net profit margin4.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers